Literature DB >> 27582606

Magnetic Resonance Imaging of the Prostate, Including Pre- and Postinterventions.

Pritesh Patel1, Aytekin Oto1.   

Abstract

This article systematically reviews the rationale for magnetic resonance imaging in prostate cancer, in detection and following various treatment methods. A basic discussion of the identification of prostate cancer is imperative to understand postintervention imaging. Each available therapy, including surgery, radiation, hormone therapy, and focal therapies will be discussed along with associated imaging findings, providing the reader with a better understanding of current interventions in prostate cancer and imaging.

Entities:  

Keywords:  focal therapy; high-intensity focused ultrasound; laser ablation; prostate MRI; prostate cancer

Year:  2016        PMID: 27582606      PMCID: PMC5005079          DOI: 10.1055/s-0036-1586144

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  20 in total

1.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2012-07-17       Impact factor: 25.391

2.  Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T.

Authors:  Inyoung Song; Chan Kyo Kim; Byung Kwan Park; Won Park
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

3.  MRI appearance of prostate following transrectal HIFU ablation of localized cancer.

Authors:  O Rouvière; D Lyonnet; A Raudrant; C Colin-Pangaud; J Y Chapelon; R Bouvier; J M Dubernard; A Gelet
Journal:  Eur Urol       Date:  2001-09       Impact factor: 20.096

4.  Computer-extracted Features Can Distinguish Noncancerous Confounding Disease from Prostatic Adenocarcinoma at Multiparametric MR Imaging.

Authors:  Geert J S Litjens; Robin Elliott; Natalie N C Shih; Michael D Feldman; Thiele Kobus; Christina Hulsbergen-van de Kaa; Jelle O Barentsz; Henkjan J Huisman; Anant Madabhushi
Journal:  Radiology       Date:  2015-07-17       Impact factor: 11.105

5.  MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer.

Authors:  Chan Kyo Kim; Byung Kwan Park; Hyun Moo Lee; Sam Soo Kim; EunJu Kim
Journal:  AJR Am J Roentgenol       Date:  2008-05       Impact factor: 3.959

Review 6.  Advances in androgen receptor targeted therapy for prostate cancer.

Authors:  Alia Ahmed; Shadan Ali; Fazlul H Sarkar
Journal:  J Cell Physiol       Date:  2014-03       Impact factor: 6.384

7.  Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide.

Authors:  Masoom A Haider; Sean R H Davidson; Ashwini V Kale; Robert A Weersink; Andrew J Evans; Ants Toi; Mark R Gertner; Arjen Bogaards; Brian C Wilson; Joseph L Chin; Mostafa Elhilali; John Trachtenberg
Journal:  Radiology       Date:  2007-05-16       Impact factor: 11.105

8.  The safety and efficacy of irreversible electroporation for the ablation of prostate cancer: a multicentre prospective human in vivo pilot study protocol.

Authors:  W van den Bos; D M de Bruin; B G Muller; I M Varkarakis; A A Karagiannis; P J Zondervan; M P Laguna Pes; D P Veelo; C D Savci Heijink; M R W Engelbrecht; H Wijkstra; T M de Reijke; J J M C H de la Rosette
Journal:  BMJ Open       Date:  2014-10-29       Impact factor: 2.692

9.  Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil.

Authors:  Hans Christian Rischke; Arnd O Schäfer; Ursula Nestle; Natalja Volegova-Neher; Karl Henne; Matthias R Benz; Wolfgang Schultze-Seemann; Mathias Langer; Anca L Grosu
Journal:  Radiat Oncol       Date:  2012-10-31       Impact factor: 3.481

10.  MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I-II study in patients undergoing IRE followed by radical prostatectomy.

Authors:  Willemien van den Bos; D M de Bruin; A van Randen; M R W Engelbrecht; A W Postema; B G Muller; I M Varkarakis; A Skolarikos; C D Savci-Heijink; R R Jurhill; P J Zondervan; M P Laguna Pes; H Wijkstra; T M de Reijke; J J M C H de la Rosette
Journal:  Eur Radiol       Date:  2015-10-08       Impact factor: 5.315

View more
  1 in total

1.  Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.

Authors:  Ricardo Alvim; Karan Nagar; Sudeep Das; Souhil Lebdai; Nathan Wong; Alexander Somma; Christopher Hughes; Jasmine Thomas; Sébastien Monette; Avigdor Scherz; Kwanghee Kim; Jan Grimm; Jonathan A Coleman
Journal:  Eur Urol Focus       Date:  2019-06-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.